Accordingly, adiponectin concentrations are decreased during pregnancy, as well as obesity and obesity-related complications, such as type 2 diabetes, cardiovascular diseases and non-alcoholic fatty liver disease [4,5]. This evidence concerns the gene ADIPOQ and obesity disorder.